| Ident. | Authors (with country if any) | Title |
|---|
| 000332 |
Gilles Lambert [France, Australie] ; Francine Petrides [Australie] ; Mathias Chatelais [France] ; Dirk J. Blom [Afrique du Sud] ; Benjamin Choque [Australie] ; Fatiha Tabet [Australie] ; Gida Wong [Australie] ; Kerry-Anne Rye [Australie] ; Amanda J. Hooper [Australie] ; John R. Burnett [Australie] ; Philip J. Barter [Australie] ; A. David Marais [Afrique du Sud] | Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects |
| 000E55 |
Roeland Huijgen [Pays-Bas] ; S. Matthijs Boekholdt [Pays-Bas] ; Benoit J. Arsenault [Pays-Bas] ; WEIHANG BAO [États-Unis] ; Jean-Michel Davaine [France] ; Fatiha Tabet [Australie] ; Francine Petrides [Australie] ; Kerry-Anne Rye [Australie] ; David A. Demicco [États-Unis] ; Philip J. Barter [Australie] ; John J. P. Kastelein [Pays-Bas] ; Gilles Lambert [France, Australie] | Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial: A Nested Case-Control Study |
| 000F93 |
Kevin Brennan [Royaume-Uni] ; Montserrat Garcia-Closas [Royaume-Uni] ; Nick Orr [Royaume-Uni] ; Olivia Fletcher [Royaume-Uni] ; Michael Jones [Royaume-Uni] ; Alan Ashworth [Royaume-Uni] ; Anthony Swerdlow [Royaume-Uni] ; Kconfab Investigators [Australie] ; Elid Riboli [Royaume-Uni] ; Paolo Vineis [Royaume-Uni, Italie] ; Miren Dorronsoro [Espagne] ; Francoise Clavel-Chapelon [France] ; Salvatore Panico [Italie] ; N. Charlotte Onland-Moret [Pays-Bas] ; Dimitrios Trichopoulos [États-Unis, Grèce] ; Rudolf Kaaks [Allemagne] ; Kay-Tee Khaw [Royaume-Uni] ; Robert Brown [Royaume-Uni] ; James M. Flanagan [Royaume-Uni] | Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk |
| 003C45 |
Laurence Morandeau [Australie] ; Patricia Remaud-Le Saec [France] ; Ali Ouadi [France] ; Karine Bultel-Riviere [France] ; Marie Mougin-Degraef [France] ; Agnès De France-Robert [France] ; Alain Faivre-Chauvet [France] ; Jean-Francois Gestin [France] | Synthesis and evaluation of a novel samarium-153 bifunctional chelating agent for radioimmunotargeting applications |
| 003D98 |
Vincent Cirimele [France] ; Marion Villain [France] ; Patrick Mura [France] ; Marc Bernard [France] ; Pascal Kintz [France] | Oral fluid testing for cannabis : On-site OraLine®. IV s.a.t. device versus GC/MS |
| 004834 |
M. Villain [France] ; M. Cheze [France] ; A. Tracqui [France] ; B. Ludes [France] ; P. Kintz [France] | Windows of detection of zolpidem in urine and hair: application to two drug facilitated sexual assaults |
| 004B05 |
Ali Ouadi [France] ; Anthony Loussouarn [France] ; Laurence Morandeau [Australie] ; Patricia Remaud [France] ; Alain Faivre-Chauvet [France] ; John Webb [Australie] ; Jean-Francois Gestin [France] | Influence of trans-1,2-diaminocyclohexane structure and mixed carboxylic/phosphonic group combinations on samarium-153 chelation capacity and stability |
| 004B34 |
Pascal Kintz [France] ; Marion Villain [France] ; Vincent Cirimele [France] ; Bertrand Ludes [France] | GHB in postmortem toxicology discrimination between endogenous production from exposure using multiple specimens |
| 004B54 |
V. Cirimele [France] ; S. Etienne [France] ; M. Villain [France] ; B. Ludes [France] ; P. Kintz [France] | Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens |
| 004C00 |
B. Cartigny [France] ; N. Azaroual [France] ; M. Imbenotte [France] ; D. Mathieu [France] ; G. Vermeersch [France] ; J. P. Goulle [France] ; M. Lherrmitte [France] | Determination of glyphosate in biological fluids by 1H and 31P NMR spectroscopy |
| 005514 |
Sylviane Carbonnelle [Belgique] ; Marc Francaux [Belgique] ; Ian Doyle [Australie] ; Xavier Dumont [Belgique] ; Claire De Burbure [Belgique] ; Georges Morel [France] ; Olivier Michel [Belgique] ; Alfred Bernard [Belgique] | Changes in serum pneumoproteins caused by short-term exposures to nitrogen trichloride in indoor chlorinated swimming pools |
| 006239 |
H. M. Dodds [Australie] ; J. Robert [France] ; L. P. Rivory [Australie] | The detection of photodegradation products of irinotecan (CPT-11, Campto®, Camptosar®), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry |
| 006935 |
L. P. Rivory [Australie, France] ; J.-F. Riou [États-Unis] ; M.-C. Haaz [France] ; S. Sable [États-Unis] ; M. Vuilhorgne [États-Unis] ; A. Commercon [États-Unis] ; S. M. Pond [Australie] ; J. Robert [France] | Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients |
